BlackRock Science and Technology Trust (NYSE: BST) is a closed-end management investment company that concentrates its investments in the equity securities of companies engaged in science and technology industries. Established in December 2018, the trust seeks to provide shareholders with total return through a combination of capital appreciation and current income. BST primarily targets firms involved in information technology, biotechnology, clean energy, advanced manufacturing, and other technology-driven sectors.
The trust’s investment strategy is rooted in fundamental, bottom-up analysis carried out by a dedicated team of research professionals at BlackRock. Portfolio managers evaluate companies based on innovation pipelines, intellectual property portfolios, market positioning and growth trajectories. BST may also employ leverage and various risk-management techniques to enhance returns and manage volatility, subject to its regulatory guidelines.
BST invests in a diversified global portfolio, with holdings spanning large-cap industry leaders and smaller, high-growth enterprises across North America, Europe and the Asia-Pacific region. By combining exposure to established technology giants with emerging innovators, the trust aims to capture long-term growth opportunities driven by secular trends such as digital transformation, next-generation therapeutics and sustainable technologies.
As part of the broader BlackRock family of funds, BlackRock Science and Technology Trust benefits from the firm’s deep research resources, institutional infrastructure and risk-management capabilities. The trust is overseen by BlackRock Advisors, led by experienced investment professionals who specialize in science and technology themes, and is governed by an independent board of trustees responsible for ensuring alignment with shareholders’ interests.
AI Generated. May Contain Errors.
